KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Minority Interest: 2017-2020

Historic Minority Interest for BeOne Medicines (ONC) over the last 4 years, with Sep 2020 value amounting to $9.0 million.

  • BeOne Medicines' Minority Interest fell 42.76% to $9.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $9.0 million, marking a year-over-year decrease of 42.76%. This contributed to the annual value of $16.1 million for FY2019, which is 11.80% up from last year.
  • Per BeOne Medicines' latest filing, its Minority Interest stood at $9.0 million for Q3 2020, which was down 11.52% from $10.2 million recorded in Q2 2020.
  • In the past 5 years, BeOne Medicines' Minority Interest ranged from a high of $17.4 million in Q2 2019 and a low of $9.0 million during Q3 2020.
  • In the last 3 years, BeOne Medicines' Minority Interest had a median value of $14.3 million in 2018 and averaged $13.9 million.
  • As far as peak fluctuations go, BeOne Medicines' Minority Interest rose by 29.07% in 2019, and later tumbled by 42.76% in 2020.
  • Over the past 4 years, BeOne Medicines' Minority Interest (Quarterly) stood at $14.4 million in 2017, then rose by 0.16% to $14.4 million in 2018, then increased by 11.80% to $16.1 million in 2019, then tumbled by 42.76% to $9.0 million in 2020.
  • Its last three reported values are $9.0 million in Q3 2020, $10.2 million for Q2 2020, and $14.8 million during Q1 2020.